Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis.
The Global Proteomics Market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Increasing need for personalized medicine, RD expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation proteomics workflows. However, reduced funding in key markets of proteomics, high cost of tools equipment and lack of skilled researchers can restrain the market growth over the assessment period.
Some of the prominent players in the global proteomics market are GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and Others.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6930
Segmentation (largest fastest):
The global proteomics market has been segmented into equipment, services and application.The market, on the basis of equipment, has been segmented into chromatography, mass spectroscopy, protein microarray, X-ray crystallography, protein fractionation and others.The global market, on the basis of services, has been segmented into laboratory services and data analysis services.
The global proteomics market, by application, has been segmented into drug discovery, clinical diagnosis and others. The clinical diagnosis segment is expected to hold the largest market share owing to the increased understanding of the relevance of investigating and understanding patterns of protein expression for diseases drug development. The drug discovery segment is anticipated to grow at the fastest CAGR owing to continuous search for alternative efficient methods to deliver enhanced drugs and increased RD investments by pharmaceutical biotechnology companies.
Geographically, the Americas is expected to dominate the global market owing to the easy availability of funds from various organizations and rising interest in personalized medicines. According to the Personalized Medicine Coalition, number of available personalized medicines increased to 113 in 2014 from 13 in 2006. Europe is expected to hold the second largest position in the global market owing to the rising cancer research activities and high funding from the government. Asia-Pacific is expected to be the fastest growing market owing to the high prevalence of cancer and rising healthcare expenditure. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/proteomics-market-6930
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312